References
Tan SL, Royston P, Campbell S, Jacobs HS, Betts J, Mason B, Edwards RG: Cumulative conception and live birth rates after in vitro fertilization. Lancet 1992;339(8806):1390–1394
Toner JP, Philput C, Jones GS, Mausher SJ: Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55(4):784–791
Ben Rafael Z, Menashe Y, Mimon R, Lipitz S, Bider D, Zolti Z, Dan U, Pariente C, Shalev J, Dor J, Lev-Ran D, Mashiach S: Limitations in the use of combined gonadotropin releasing hormomone analog and human menopausal gonadotropin for in vitro fertilization.In Advances in Assisted Reproductive Technologies, S Mashiach, Z Ben Rafae, N Laufer, JA Schenker (eds.) New York London, Plenum Press, 1990, pp. 17–29
Howles CM, Macnamee MC, Edwards RG: Short term use of an LHRH agonist to treat poor responders entering an in vitro fertilization programme. Hum Reprod 1987;2:655–656
Macnamee MC, Howles CM, Edwards RG, Taylor PJ, Elder KT: Short term luteinizing hormone-releasing hormone agonist treatment; Prospective trial of a novel ovarian stimulating regimen for in vitro fertilization. Fertil Steril 1989;52:264–269
Check JH, Chase JS: Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy. Fertil Steril 1984;42:919–922
Sauer MV: Extending reproductive potential in the older woman.In Treatment of the Postmenopausal Woman, RA Lobo (ed). New York, Raven Press, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindheim, S.R., Barad, D.H., Witt, B. et al. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet 13, 745–747 (1996). https://doi.org/10.1007/BF02066431
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02066431